Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03063996 · ClinicalTrials.gov registry record · NA
Peripheral Internal Jugular Vein ('Peripheral IJ') Access in Patients Identified as Difficult Intravenous Access
A NA study of Difficult IV Access, sponsored by HealthPartners Institute.
- Completed
- Registry status
- NA
- Development phase
- 29
- Enrollment target
- 1
- Study location
NCT03063996 is a NA study of Difficult IV Access that has completed, run by HealthPartners Institute. The registered enrollment target is 29 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03063996, a NA study of Difficult IV Access, has completed, sponsored by HealthPartners Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 29 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary aim of this study is to determine if the insertion of a peripheral Internal Jugular (IJ) catheter is faster than a standard of care intravenous (IV)access in patients with difficult access. The secondary aims of this study examine patient discomfort between standard IV insertion vs. peripheral IV insertion as well as a comparison of complication rates between the two methods of insertion. Support for the peripheral IV procedure could provide an option for the thousands of Emergency Department (ED) patients who daily encounter the situation of difficult IV access and the numerous needle pokes that accompany it. Using this procedure may result in greater patient satisfaction and reduced complication rates.
Conditions Studied
Interventions
- PROCEDURE peripheral IV access procedure
- PROCEDURE Peripheral IJ access procedure
Study Locations (1)
Minnesota
- Regions Hospital - Saint Paul
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2017-02-07 |
| Est. Completion | 2018-06-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03063996
The ClinicalTrials.gov registry entry for NCT03063996 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is HealthPartners Institute, which has 146 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Difficult IV Access appearing as the primary indexed condition, and to 2 interventions - of which peripheral IV access procedure is the first listed.
NCT03063996 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT03063996 about?
NCT03063996 is a clinical study titled "Peripheral Internal Jugular Vein ('Peripheral IJ') Access in Patients Identified as Difficult Intravenous Access". The primary aim of this study is to determine if the insertion of a peripheral Internal Jugular (IJ) catheter is faster than a standard of care intravenous (IV)access in patients with difficult access. The secondary aims of this study examine patient discomfort between standard IV insertion vs. peri...
What is the current status of trial NCT03063996?
This trial is currently completed. It is a NA study. The enrollment target is 29 participants. The study started on 2017-02-07. Estimated completion is 2018-06-12.
What conditions does trial NCT03063996 study?
This clinical trial studies the following conditions: Difficult IV Access.
What interventions are being tested in trial NCT03063996?
The interventions under investigation include: peripheral IV access procedure (PROCEDURE), Peripheral IJ access procedure (PROCEDURE).
Who is sponsoring clinical trial NCT03063996?
This trial is sponsored by HealthPartners Institute, which has 146 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03063996 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.